ANN RAHE: Open Payments
NPI 1962916023 · BRIDGMAN, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$387 in 20 payments from 12 companies in 2025. Trend: 2023 $111 · 2024 $250 · 2025 $387
Food & beverage: $387
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $88 |
| AstraZeneca Pharmaceuticals LP | 4 | $67 |
| Eisai Inc. | 2 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Abbott Laboratories | 1 | $23 |
| Dexcom, Inc. | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
Products named: Wegovy, FARXIGA, Leqembi, Kerendia, AIRSUPRA, LEQVIO, Rybelsus, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
